Immune Checkpoint Inhibitor Associated Polymyositis: A case of Nivolumab-Induced Myotoxicity

Author Information

• Maya PillaiFollow
• Rohan DhamsaniaFollow
• Evan CuffFollow
• Raza ZarrarFollow

Keywords:

Nivolumab, polymyositis, myotoxicity

Recommended Citation

Pillai, Maya; Dhamsania, Rohan; Cuff, Evan; and Zarrar, Raza, "Immune Checkpoint Inhibitor Associated Polymyositis: A case of Nivolumab-Induced Myotoxicity" (2026). Tower Health Research Day. 5.
https://scholarcommons.towerhealth.org/th_researchday/2025-2026/online_posters/5

Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt

Not Applicable